FDA OKs Voluven for post-op blood loss

Dec 28, 2007

The U.S. Food and Drug Administration has approved Voluven as a treatment for blood loss after surgery.

Voluven is an intravenous solution that expands blood volume, the agency said Thursday in a release.

Significant blood loss can cause a rapid drop in the volume of red blood cells and plasma circulating through the body. This can lead to shock, which is potentially fatal.

Blood volume expanders are commonly administered to restore quickly some of the lost volume so remaining red blood cells can continue to deliver needed oxygen to the body's tissues, the FDA said.

Voluven, made by the German-firm Fresenius Kabi, contains a synthetic starch that does not dissolve in water. It was found in clinical trials to be as safe and effective as other blood volume expanders, the agency said.

The most common side effects from Voluven were nausea and itching.

Copyright 2007 by United Press International

Explore further: FDA approves new drugs for irritable bowel syndrome

Related Stories

Say Freeze: Photogs do 365-gigapixel sweep of Mont Blanc

1 hour ago

Mont Blanc is the highest mountain in the Alps and has taken on an added distinction as the subject of the world's largest photograph. The Telegraph reported Monday that a photography team accomplished a worl ...

Blueprint for a thirsty world from Down Under

3 hours ago

The Millennium Drought in southeastern Australia forced Greater Melbourne, a city of 4.3 million people, to successfully implement innovations that hold critical lessons for water-stressed regions around the world, according ...

Recommended for you

US appeals court upholds delay in Alzheimer's drug swap

May 22, 2015

A federal appeals court has rejected a drug manufacturer's appeal and affirmed a judge's order that Actavis PLC keep distributing its widely used Alzheimer's medication until after its patent expires this summer.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.